This inventor holds 1 USPTO granted patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Matthew Collins - Innovator in Zika Research
Introduction
Matthew Collins is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medical research, particularly in the development of neutralizing antibodies for Zika virus.
Latest Patents
Matthew Collins holds a patent for "Highly Specific Zika Neutralizing Human Antibodies." This innovative work aims to provide effective solutions for combating the Zika virus, which has posed serious health risks globally.
Career Highlights
Collins is affiliated with The University of North Carolina at Chapel Hill, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential impact on public health.
Collaborations
He has worked alongside notable colleagues, including Huy Tu and Ben McElvany, contributing to a collaborative environment that fosters innovation and discovery.
Conclusion
Matthew Collins exemplifies the spirit of innovation in medical research, particularly through his work on Zika neutralizing antibodies. His contributions are vital in the ongoing fight against viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile